Cyclin E2 Antibody

About the Target

CCNE2 is a target of interest in many antibody-based workflows. Cyclin E1 and Cyclin E2 are regulatory proteins that activate CDK2. In response to DNA damage, the upregulation or activation of CDK inhibitors such as p21 Waf1/Cip1 and p27 Kip1 inhibits the activation of cyclin E/CDK2, leading to G1/S phase arrest. Under conditions favorable for cell cycle progression, cyclin D/CDK4/6 complexes phosphorylate the retinoblastoma protein (Rb), which is thought to diminish the inhibitory effects of p21 Waf1/Cip1 and p27 Kip1, thereby enabling the activation of cyclin E/CDK2. Depending on the literature source, CCNE2 may also be discussed as Cyclin E2.

Reported cellular context includes nucleus, which can matter when signal is compared across treatments or changing cell states. Following CCNE2 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

CCNE2 is commonly interpreted in the context of cell cycle research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• signal enrichment within nucleus relative to the broader cellular background
• cell-cycle linked differences in abundance, timing, or compartmental enrichment
• co-patterning with orthogonal markers and control conditions that clarify pathway state
• time-matched comparisons so changes reflect biology rather than handling or sampling drift

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for CCNE2. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in CCNE2 reflect biology rather than handling. When interpreting CCNE2, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep CCNE2 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.